Masimo is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Catherine Szyman, with a market cap of $9.3B.
Common questions about Masimo
Masimo is scheduled to report earnings for Q1 2026 on May 5, 2026 after market close. Analysts estimate revenue of $398.7M.
Masimo has approximately 3,796 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.